CircPRDM2 Contributes to Doxorubicin Resistance of Osteosarcoma by Elevating EZH2 via Sponging miR-760

References

• Lindsey BA, Markel JE, Kleinerman ES. Osteosarcoma overview. Rheumatol Ther. 2017;4(1):25–43. doi:10.1007/s40744-016-0050-227933467
   PubMed Web of Science ®Google Scholar
• Chen L, Zou X, Wang Y, Mao Y, Zhou L. Central nervous system tumors: a single center pathology review of 34,140 cases over 60 years. BMC Clin Pathol. 2013;13(1):14. doi:10.1186/1472-6890-13-1423639346
   PubMedGoogle Scholar
• Federman N, Bernthal N, Eilber FC, Tap WD. The multidisciplinary management of osteosarcoma. Curr Treat Options Oncol. 2009;10(1–2):82–93. doi:10.1007/s11864-009-0087-319238553
   PubMed Web of Science ®Google Scholar
• Harrison DJ, Geller DS, Gill JD, Lewis VO, Gorlick R. Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 2018;18(1):39–50. doi:10.1080/14737140.2018.141393929210294
   PubMed Web of Science ®Google Scholar
• Botter SM, Neri D, Fuchs B. Recent advances in osteosarcoma. Curr Opin Pharmacol. 2014;16:15–23. doi:10.1016/j.coph.2014.02.00224632219
   PubMed Web of Science ®Google Scholar
• Chou AJ, Gorlick R. Chemotherapy resistance in osteosarcoma: current challenges and future directions. Expert Rev Anticancer Ther. 2006;6(7):1075–1085. doi:10.1586/14737140.6.7.107516831079
   PubMed Web of Science ®Google Scholar
• Das A, Gorospe M, Panda AC. The coding potential of circRNAs. Aging (Albany NY). 2018;10(9):2228–2229. doi:10.18632/aging.10155430215602
   PubMedGoogle Scholar
• Li X, Yang L, Chen LL. The biogenesis, functions, and challenges of circular RNAs. Mol Cell. 2018;71(3):428–442. doi:10.1016/j.molcel.2018.06.03430057200
   PubMed Web of Science ®Google Scholar
• Hentze MW, Preiss T. Circular RNAs: splicing’s enigma variations. EMBO J. 2013;32(7):923–925. doi:10.1038/emboj.2013.5323463100
   PubMed Web of Science ®Google Scholar
• Xie C, Liang G, Xu Y, Lin E. Circular RNA hsa_circ_0003496 contributes to tumorigenesis and chemoresistance in osteosarcoma through targeting (microRNA) miR-370/kruppel-like factor 12 axis. Cancer Manag Res. 2020;12:8229–8240. doi:10.2147/CMAR.S25396932982419
   PubMed Web of Science ®Google Scholar
• Li X, Liu Y, Zhang X, et al. Circular RNA hsa_circ_0000073 contributes to osteosarcoma cell proliferation, migration, invasion and methotrexate resistance by sponging miR-145-5p and miR-151-3p and upregulating NRAS. Aging (Albany NY). 2020;12(14):14157–14173. doi:10.18632/aging.10342332706759
   PubMedGoogle Scholar
• Liu X, Zhong Y, Li J, Shan A. Circular RNA circ-NT5C2 acts as an oncogene in osteosarcoma proliferation and metastasis through targeting miR-448. Oncotarget. 2017;8(70):114829–114838. doi:10.18632/oncotarget.2216229383123
   PubMedGoogle Scholar
• Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. MicroRNA expression and function in cancer. Trends Mol Med. 2006;12(12):580–587. doi:10.1016/j.molmed.2006.10.00617071139
   PubMed Web of Science ®Google Scholar
• Acunzo M, Romano G, Wernicke D, Croce CM. MicroRNA and cancer–a brief overview. Adv Biol Regul. 2015;57:1–9. doi:10.1016/j.jbior.2014.09.01325294678
   PubMedGoogle Scholar
• Wang Y, Wang H, Zhang J, et al. Circ_0007031 serves as a sponge of miR-760 to regulate the growth and chemoradiotherapy resistance of colorectal cancer via regulating DCP1A. Cancer Manag Res. 2020;12:8465–8479. doi:10.2147/CMAR.S25481532982440
   PubMed Web of Science ®Google Scholar
• Yang D, Hu Z, Xu J, et al. MiR-760 enhances sensitivity of pancreatic cancer cells to gemcitabine through modulating Integrin beta1. Biosci Rep. 2019;39(11):BSR20192358. doi:10.1042/BSR2019235831693728
   PubMed Web of Science ®Google Scholar
• Yin R, Liu J, Zhao D, Wang F. Long non-coding RNA ASB16-AS1 functions as a miR-760 sponge to facilitate the malignant phenotype of osteosarcoma by increasing HDGF expression. Onco Targets Ther. 2020;13:2261–2274. doi:10.2147/OTT.S24002232214826
   PubMed Web of Science ®Google Scholar
• Tsang DP, Cheng AS. Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. J Gastroenterol Hepatol. 2011;26(1):19–27. doi:10.1111/j.1440-1746.2010.06447.x
   PubMed Web of Science ®Google Scholar
• Zhu Z, Tang J, Wang J, Duan G, Zhou L, Zhou X. MiR-138 acts as a tumor suppressor by targeting EZH2 and enhances cisplatin-induced apoptosis in osteosarcoma cells. PLoS One. 2016;11(3):e0150026. doi:10.1371/journal.pone.015002627019355
   PubMed Web of Science ®Google Scholar
• Ferrari S, Ruggieri P, Cefalo G, et al. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1. J Clin Oncol. 2012;30(17):2112–2118. doi:10.1200/JCO.2011.38.442022564997
   PubMed Web of Science ®Google Scholar
• Vijayanarasimha D, Nayanar SK, Vikram S, Patil VM, Babu S, Satheesan B. Clinico-pathological study of limb salvage surgery for osteosarcoma: experience in a rural cancer center. Indian J Surg Oncol. 2017;8(2):136–141. doi:10.1007/s13193-016-0547-828546707
   PubMed Web of Science ®Google Scholar
• Zhang H, Yan J, Lang X, Zhuang Y. Expression of circ_001569 is upregulated in osteosarcoma and promotes cell proliferation and cisplatin resistance by activating the Wnt/beta-catenin signaling pathway. Oncol Lett. 2018;16(5):5856–5862. doi:10.3892/ol.2018.941030344736
   PubMed Web of Science ®Google Scholar
• Kun-Peng Z, Xiao-Long M, Lei Z, Chun-Lin Z, Jian-Ping H, Tai-Cheng Z. Screening circular RNA related to chemotherapeutic resistance in osteosarcoma by RNA sequencing. Epigenomics. 2018;10(10):1327–1346. doi:10.2217/epi-2018-002330191736
   PubMed Web of Science ®Google Scholar
• Lei S, Xiang L. Up-regulation of circRNA hsa_circ_0003074 expression is a reliable diagnostic and prognostic biomarker in patients with osteosarcoma. Cancer Manag Res. 2020;12:9315–9325. doi:10.2147/CMAR.S26209333061621
   PubMed Web of Science ®Google Scholar
• Fu L, Chen Q, Yao T, et al. Hsa_circ_0005986 inhibits carcinogenesis by acting as a miR-129-5p sponge and is used as a novel biomarker for hepatocellular carcinoma. Oncotarget. 2017;8(27):43878–43888. doi:10.18632/oncotarget.1670928410211
   PubMedGoogle Scholar
• Li S, Sun W, Wang H, Zuo D, Hua Y, Cai Z. Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal. Tumour Biol. 2015;36(3):1329–1338. doi:10.1007/s13277-015-3181-025666750
   PubMed Web of Science ®Google Scholar
• Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1(5):555–567. doi:10.1016/j.stem.2007.08.01418371393
   PubMed Web of Science ®Google Scholar
• Li B, Lu Y, Wang H, et al. miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway. Biomed Pharmacother. 2016;79:93–101. doi:10.1016/j.biopha.2016.01.04527044817
   PubMed Web of Science ®Google Scholar
• Wang K, Hu YB, Zhao Y, Ye C. LncRNA ANRIL regulates ovarian cancer progression and tumor stem cell-like characteristics via miR-324-5p/ran axis. Onco Targets Ther. 2021;14:565–576. doi:10.2147/OTT.S27361433500630
   PubMed Web of Science ®Google Scholar
• Qian L, Liu F, Chu Y, et al. MicroRNA-200c nanoparticles sensitized gastric cancer cells to radiotherapy by regulating PD-L1 expression and EMT. Cancer Manag Res. 2020;12:12215–12223. doi:10.2147/CMAR.S27997833273858
   PubMed Web of Science ®Google Scholar
• Cheng M, Duan PG, Gao ZZ, Dai M. MicroRNA487b3p inhibits osteosarcoma chemoresistance and metastasis by targeting ALDH1A3. Oncol Rep. 2020;44(6):2691–2700. doi:10.3892/or.2020.781433125503
   PubMed Web of Science ®Google Scholar
• Cao L, Liu Y, Wang D, et al. MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling. J Exp Clin Cancer Res. 2018;37(1):83. doi:10.1186/s13046-018-0757-829661228
   PubMed Web of Science ®Google Scholar
• Li Q, Lu J, Xia J, Wen M, Wang C. Long non-coding RNA LOC730100 enhances proliferation and invasion of glioma cells through competitively sponging miR-760 from FOXA1 mRNA. Biochem Biophys Res Commun. 2019;512(3):558–563. doi:10.1016/j.bbrc.2019.03.12430914197
   PubMed Web of Science ®Google Scholar
• Liu W, Li Y, Feng S, Guan Y, Cao Y. MicroRNA-760 inhibits cell viability and migration through down-regulating BST2 in gastric cancer. J Biochem. 2020;168(2):159–170. doi:10.1093/jb/mvaa03132167539
   PubMed Web of Science ®Google Scholar
• Xian D, Zhao Y. LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway. J Cell Mol Med. 2019;23(6):3808–3823. doi:10.1111/jcmm.1407130997746
   PubMed Web of Science ®Google Scholar